中国学者近期发表的论文
1.	High expression of PTPN21 in B-cell non-Hodgkin's gastric lymphoma, a positive mediator of STAT5 activity. Author: Plani-Lam JH, Chow TC, Fan YH, Garcia-Bloj B, Cheng L, Jin DY, Hancock W, Fanayan S, Ingley E, Song YQ. Journal: Blood Cancer J. 2016 Jan 15;6:e388. doi: 10.1038/bcj.2015.107. No abstract available.     PubMed
2.	Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study. Author: Lu A, Fang Y, Du X, Li Y, Cai Z, Yu K, Zhao L, Wang B, Wu J, Cheng Y, Zuo Y, Jia Y, Tan F, Ding L, Lu J, Zhang L, Huang X. Journal: Blood Cancer J. 2016 Feb 26;6:e400. doi: 10.1038/bcj.2016.8. No abstract available.     PubMed
3.	The microenvironment of classical Hodgkin lymphoma: heterogeneity by Epstein-Barr virus presence and location within the tumor. Author: Wu R, Sattarzadeh A, Rutgers B, Diepstra A, van den Berg A, Visser L. Journal: Blood Cancer J. 2016 May 6;6:e417. doi: 10.1038/bcj.2016.26. No abstract available.     PubMed
4.	Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Author: Chen Z, Wang W, Cortes JE, Liu E, Miranda RN, Zhao C, Yuan J, Lu X, Yang W, Ameri MD, Kantarjian HM, Medeiros LJ, Hu S. Journal: Blood Cancer J. 2016 May 6;6:e418. doi: 10.1038/bcj.2016.27. No abstract available.     PubMed
5.	Next-generation sequencing with a myeloid gene panel in core-binding factor AML showed KIT activation loop and TET2 mutations predictive of outcome. Author: Cher CY, Leung GM, Au CH, Chan TL, Ma ES, Sim JP, Gill H, Lie AK, Liang R, Wong KF, Siu LL, Tsui CS, So CC, Wong HW, Yip SF, Lee HK, Liu HS, Lau JS, Luk TH, Lau CK, Lin SY, Kwong YL, Leung AY. Journal: Blood Cancer J. 2016 Jul 8;6(7):e442. doi: 10.1038/bcj.2016.51.    PubMed
6.	Reprogramming of Notch1-induced acute lymphoblastic leukemia cells into pluripotent stem cells in mice. Author: Zhang H, Cheng H, Wang Y, Zheng Y, Liu Y, Liu K, Xu J, Hao S, Yuan W, Zhao T, Cheng T. Journal: Blood Cancer J. 2016 Jul 8;6(7):e444. doi: 10.1038/bcj.2016.57. No abstract available.     PubMed
7.	Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi- Author: huangxiaojun Journal: Blood Cancer Journal, 2016.
8.	Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi- Author: zhangleping Journal: Blood Cancer Journal, 2016.
9.	Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi- Author: jin1lu Journal: Blood Cancer Journal, 2016.

同类著名期刊名称 h-index CiteScore CA-A CANCER JOURNAL FOR CLINICIANS 144 435.40 NEW ENGLAND JOURNAL OF MEDICINE 933 66.10 NATURE REVIEWS DRUG DISCOVERY 289 35.50 LANCET 700 73.40 Nature Reviews Clinical Oncology 127 37.50 NATURE REVIEWS CANCER 396 70.40 JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 622 26.30 Nature Reviews Disease Primers 48 42.20 World Psychiatry 61 32.80 World Psychiatry 70 32.80

中科院JCR同大类学科的热搜期刊 浏览次数 MEDICINE 302551 CANCER RESEARCH 166752 Molecular Medicine Reports 165685 International Journal of Nanomedicine 165278 CANCER LETTERS 160433 JOURNAL OF ETHNOPHARMACOLOGY 142762 BIOMEDICINE & PHARMACOTHERAPY 142080 Theranostics 137051 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 136855 International Journal of Environmental Research and Public Health 134508